KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Long-Term Investments (2016 - 2025)

Historic Long-Term Investments for Regeneron Pharmaceuticals (REGN) over the last 17 years, with Q4 2025 value amounting to $10.3 billion.

  • Regeneron Pharmaceuticals' Long-Term Investments rose 1528.63% to $10.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $10.3 billion, marking a year-over-year increase of 1528.63%. This contributed to the annual value of $10.3 billion for FY2025, which is 1528.63% up from last year.
  • Regeneron Pharmaceuticals' Long-Term Investments amounted to $10.3 billion in Q4 2025, which was up 1528.63% from $10.3 billion recorded in Q3 2025.
  • In the past 5 years, Regeneron Pharmaceuticals' Long-Term Investments registered a high of $10.3 billion during Q3 2025, and its lowest value of $3.5 billion during Q1 2021.
  • Its 5-year average for Long-Term Investments is $7.1 billion, with a median of $6.7 billion in 2021.
  • Per our database at Business Quant, Regeneron Pharmaceuticals' Long-Term Investments surged by 11807.63% in 2021 and then crashed by 1813.31% in 2023.
  • Quarter analysis of 5 years shows Regeneron Pharmaceuticals' Long-Term Investments stood at $6.8 billion in 2021, then decreased by 3.6% to $6.6 billion in 2022, then decreased by 18.13% to $5.4 billion in 2023, then surged by 64.92% to $8.9 billion in 2024, then rose by 15.29% to $10.3 billion in 2025.
  • Its Long-Term Investments was $10.3 billion in Q4 2025, compared to $10.3 billion in Q3 2025 and $10.1 billion in Q2 2025.